BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24954872)

  • 1. Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients.
    Renieri A; Mencarelli MA; Cetta F; Baldassarri M; Mari F; Furini S; Piu P; Ariani F; Dragani TA; Frullanti E
    Lung Cancer; 2014 Aug; 85(2):168-74. PubMed ID: 24954872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer.
    Liu Y; Kheradmand F; Davis CF; Scheurer ME; Wheeler D; Tsavachidis S; Armstrong G; Simpson C; Mandal D; Kupert E; Anderson M; You M; Xiong D; Pikielny C; Schwartz AG; Bailey-Wilson J; Gaba C; De Andrade M; Yang P; Pinney SM; ; Amos CI; Spitz MR
    J Thorac Oncol; 2016 Jan; 11(1):52-61. PubMed ID: 26762739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic basis for susceptibility to lung cancer: Recent progress and future directions.
    Yokota J; Shiraishi K; Kohno T
    Adv Cancer Res; 2010; 109():51-72. PubMed ID: 21070914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omic Approach in Non-smoker Female with Lung Squamous Cell Carcinoma Pinpoints to Germline Susceptibility and Personalized Medicine.
    Baldassarri M; Fallerini C; Cetta F; Ghisalberti M; Bellan C; Furini S; Spiga O; Crispino S; Gotti G; Ariani F; Paladini P; Renieri A; Frullanti E
    Cancer Res Treat; 2018 Apr; 50(2):356-365. PubMed ID: 28546520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma.
    Preusser M; Berghoff AS; Koller R; Zielinski CC; Hainfellner JA; Liebmann-Reindl S; Popitsch N; Geier CB; Streubel B; Birner P
    Eur J Cancer; 2015 Sep; 51(13):1803-11. PubMed ID: 26164066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissue.
    Fehringer G; Liu G; Pintilie M; Sykes J; Cheng D; Liu N; Chen Z; Seymour L; Der SD; Shepherd FA; Tsao MS; Hung RJ
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1097-104. PubMed ID: 22539604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations.
    Seow WJ; Matsuo K; Hsiung CA; Shiraishi K; Song M; Kim HN; Wong MP; Hong YC; Hosgood HD; Wang Z; Chang IS; Wang JC; Chatterjee N; Tucker M; Wei H; Mitsudomi T; Zheng W; Kim JH; Zhou B; Caporaso NE; Albanes D; Shin MH; Chung LP; An SJ; Wang P; Zheng H; Yatabe Y; Zhang XC; Kim YT; Shu XO; Kim YC; Bassig BA; Chang J; Ho JC; Ji BT; Kubo M; Daigo Y; Ito H; Momozawa Y; Ashikawa K; Kamatani Y; Honda T; Sakamoto H; Kunitoh H; Tsuta K; Watanabe SI; Nokihara H; Miyagi Y; Nakayama H; Matsumoto S; Tsuboi M; Goto K; Yin Z; Shi J; Takahashi A; Goto A; Minamiya Y; Shimizu K; Tanaka K; Wu T; Wei F; Wong JY; Matsuda F; Su J; Kim YH; Oh IJ; Song F; Lee VH; Su WC; Chen YM; Chang GC; Chen KY; Huang MS; Yang PC; Lin HC; Xiang YB; Seow A; Park JY; Kweon SS; Chen CJ; Li H; Gao YT; Wu C; Qian B; Lu D; Liu J; Jeon HS; Hsiao CF; Sung JS; Tsai YH; Jung YJ; Guo H; Hu Z; Wang WC; Chung CC; Lawrence C; Burdett L; Yeager M; Jacobs KB; Hutchinson A; Berndt SI; He X; Wu W; Wang J; Li Y; Choi JE; Park KH; Sung SW; Liu L; Kang CH; Hu L; Chen CH; Yang TY; Xu J; Guan P; Tan W; Wang CL; Sihoe AD; Chen Y; Choi YY; Hung JY; Kim JS; Yoon HI; Cai Q; Lin CC; Park IK; Xu P; Dong J; Kim C; He Q; Perng RP; Chen CY; Vermeulen R; Wu J; Lim WY; Chen KC; Chan JK; Chu M; Li YJ; Li J; Chen H; Yu CJ; Jin L; Lo YL; Chen YH; Fraumeni JF; Liu J; Yamaji T; Yang Y; Hicks B; Wyatt K; Li SA; Dai J; Ma H; Jin G; Song B; Wang Z; Cheng S; Li X; Ren Y; Cui P; Iwasaki M; Shimazu T; Tsugane S; Zhu J; Jiang G; Fei K; Wu G; Chien LH; Chen HL; Su YC; Tsai FY; Chen YS; Yu J; Stevens VL; Laird-Offringa IA; Marconett CN; Lin D; Chen K; Wu YL; Landi MT; Shen H; Rothman N; Kohno T; Chanock SJ; Lan Q
    Hum Mol Genet; 2017 Jan; 26(2):454-465. PubMed ID: 28025329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of germline mutations in smokers and non-smokers in Brazilian non-small-cell lung cancer (NSCLC) patients.
    Couto PP; Bastos-Rodrigues L; Schayek H; Melo FM; Lisboa RGC; Miranda DM; Vilhena A; Bale AE; Friedman E; De Marco L
    Carcinogenesis; 2017 Oct; 38(11):1112-1118. PubMed ID: 28968711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.
    Wang Y; Broderick P; Matakidou A; Eisen T; Houlston RS
    Carcinogenesis; 2010 Feb; 31(2):234-8. PubMed ID: 19955392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline Mutations in DNA Repair Genes in Lung Adenocarcinoma.
    Parry EM; Gable DL; Stanley SE; Khalil SE; Antonescu V; Florea L; Armanios M
    J Thorac Oncol; 2017 Nov; 12(11):1673-1678. PubMed ID: 28843361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability.
    Chen HY; Yu SL; Ho BC; Su KY; Hsu YC; Chang CS; Li YC; Yang SY; Hsu PY; Ho H; Chang YH; Chen CY; Yang HI; Hsu CP; Yang TY; Chen KC; Hsu KH; Tseng JS; Hsia JY; Chuang CY; Yuan S; Lee MH; Liu CH; Wu GI; Hsiung CA; Chen YM; Wang CL; Huang MS; Yu CJ; Chen KY; Tsai YH; Su WC; Chen HW; Chen JJ; Chen CJ; Chang GC; Yang PC; Li KC
    J Clin Oncol; 2015 Jul; 33(20):2303-10. PubMed ID: 26056182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline mutations in young non-smoking women with lung adenocarcinoma.
    Donner I; Katainen R; Sipilä LJ; Aavikko M; Pukkala E; Aaltonen LA
    Lung Cancer; 2018 Aug; 122():76-82. PubMed ID: 30032850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.
    Xia S; Huang CC; Le M; Dittmar R; Du M; Yuan T; Guo Y; Wang Y; Wang X; Tsai S; Suster S; Mackinnon AC; Wang L
    Lung Cancer; 2015 Oct; 90(1):78-84. PubMed ID: 26233568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole genome sequencing analysis of lung adenocarcinoma in Xuanwei, China.
    Wang X; Li J; Duan Y; Wu H; Xu Q; Zhang Y
    Thorac Cancer; 2017 Mar; 8(2):88-96. PubMed ID: 28083984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.
    Imielinski M; Berger AH; Hammerman PS; Hernandez B; Pugh TJ; Hodis E; Cho J; Suh J; Capelletti M; Sivachenko A; Sougnez C; Auclair D; Lawrence MS; Stojanov P; Cibulskis K; Choi K; de Waal L; Sharifnia T; Brooks A; Greulich H; Banerji S; Zander T; Seidel D; Leenders F; Ansén S; Ludwig C; Engel-Riedel W; Stoelben E; Wolf J; Goparju C; Thompson K; Winckler W; Kwiatkowski D; Johnson BE; Jänne PA; Miller VA; Pao W; Travis WD; Pass HI; Gabriel SB; Lander ES; Thomas RK; Garraway LA; Getz G; Meyerson M
    Cell; 2012 Sep; 150(6):1107-20. PubMed ID: 22980975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.
    Garofalo A; Sholl L; Reardon B; Taylor-Weiner A; Amin-Mansour A; Miao D; Liu D; Oliver N; MacConaill L; Ducar M; Rojas-Rudilla V; Giannakis M; Ghazani A; Gray S; Janne P; Garber J; Joffe S; Lindeman N; Wagle N; Garraway LA; Van Allen EM
    Genome Med; 2016 Jul; 8(1):79. PubMed ID: 27460824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma.
    Han JY; Kim SH; Lee YS; Lee SY; Hwang JA; Kim JY; Yoon SJ; Lee GK
    Lung Cancer; 2014 Aug; 85(2):161-7. PubMed ID: 24857785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
    Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK
    PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of somatic alterations in stage I lung adenocarcinomas by next-generation sequencing.
    Zhao Y; Yang J; Chen Z; Gao Z; Zhou F; Li X; Li J; Shi S; Feng X; Sun N; Yao R; Zhou C; Chang S; Li M; Zhou Y; Li L; Zhang X; He J
    Genes Chromosomes Cancer; 2014 Apr; 53(4):289-98. PubMed ID: 24449147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.